ClinicalTrials.Veeva

Menu

Effect of CoQ10 on the Endocrine Function of Skeletal Muscle

M

Medical University of Gdansk

Status

Not yet enrolling

Conditions

Exercise Training
Coenzyme Q Deficiency
Ischemic Preconditioning

Treatments

Procedure: Ischemic preconditioning training
Dietary Supplement: Sham IPC combined with placebo
Dietary Supplement: CoQ10 supplementation
Dietary Supplement: IPC training combined with CoQ10 supplementation

Study type

Interventional

Funder types

Other

Identifiers

NCT05412888
MUGdansk CoQ10

Details and patient eligibility

About

Recent studies have also shown that repeated episodes of ischemia, followed by reperfusion (IPC), can contribute to the development of adaptive changes not only in the area of the heart muscle, but also in the structure of the skeletal muscles.

In the project, several research questions will be evaluated e.g. what is the relationship between oxidative stress parameters, uric acid concentration and nitric oxide degradation products in groups of people undergoing two-week training in ischemic training, or what is the relationship between the expression of genes associated with muscle cell growth (e.g. myostatin gene) and the effect of ischemia preconditioning training etc.

Full description

Both in sport and medicine, methods are constantly sought that can significantly contribute to improving the ability of tissues to perform their functions and protecting them from effort-induced damage.

In a wide range of interests, especially in people treated for ischemic changes of cardiovascular diseases, are protocols of tissue preconditioning by transient ischemia which significantly contribute to the increase in blood flow in tissue structure.

Recent studies have also shown that repeated episodes of ischemia, followed by reperfusion (IPC), can contribute to the development of adaptive changes not only in the area of the heart muscle, but also in the structure of the skeletal muscles. There is still a lack of detailed research on genetic conditions related to adaptive changes in this area of interest.

In the project, the following research questions were posed:

  1. What is the relationship between oxidative stress parameters, uric acid concentration and nitric oxide degradation products in groups of people undergoing two-week training in IPC training, or 2 weeks of CoQ10 supplementation in the light of non-training and non-supplementation?
  2. What is the relationship between two weeks of lower limb ischemia preconditioning training, or CoQ10 supplementation, and the expression of genes associated with the stress response (HSF-1, NF-kB, TNF dependent glass)?
  3. What is the relationship between the expression of genes associated with muscle cell growth (e.g. myostatin gene) and the effect of preconditioning training by ischemia?
  4. What is the relationship between the expression of genes associated with intracellular metabolism and the effect of CoQ10 supplementation?
  5. What is the relationship between the expression of genes encoding enzymes of energy pathways (e.g. GAPDH, LDH) and IPC training or CoQ10 supplementation in the study group?
  6. How does IPC training or CoQ10 supplementation affect the expression of genes responsible for membrane transport, and the Hedgehog pathway in muscle cells (including Gli1)?
  7. How does IPC training affect the expression of transcription factors: Hif-1-alpha (hypoxia-induced factor) and NF-kB and selected genes dependent on their activity?

HYPOTHESIS The level of gene expression associated with oxidative stress, muscle fiber development, angiogenesis, muscle cell energy, and membrane transport will change under the influence of the use of preconditioning training by deficiency or CoQ10 supplementation

Enrollment

100 estimated patients

Sex

Male

Ages

21 to 29 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: - gender (males only),

  • not taking medication during the study,
  • good health (no concomitant injuries),
  • negative history of cardiovascular disorders, autonomic nervous system, mental disorders, cerebrospinal injuries and other diseases that may directly affect the results obtained.

Exclusion Criteria:

Lack of consent to participate in the research project or negative result of medical examinations.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 4 patient groups, including a placebo group

Supplemented population 300mg
Placebo Comparator group
Description:
Supplemented population 300mg/24h CoQ10 - 25 participants
Treatment:
Dietary Supplement: CoQ10 supplementation
Training and IPC preconditioning
Experimental group
Description:
Group subjected to training and preconditioning by ischemia (IPC training) - 25 participants,
Treatment:
Procedure: Ischemic preconditioning training
Control group (placebo)
Placebo Comparator group
Description:
Control group to CoQ10 supplementation (placebo)- 25 participants
Treatment:
Dietary Supplement: Sham IPC combined with placebo
IPC control group
Sham Comparator group
Description:
IPC control group - 25 participants
Treatment:
Dietary Supplement: IPC training combined with CoQ10 supplementation

Trial contacts and locations

1

Loading...

Central trial contact

Jedrzej Antosiewicz; Jedrzej Antosiewicz

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems